Search results
- 1.0580604 - ÚOCHB 2024 RIV eng P - Patent Document
Birkuš, Gabriel - Dejmek, Milan - Nencka, Radim - Otava, Tomáš - Šála, Michal - Páv, Ondřej
3'3' cyclic dinucleotides with an alkenylene.
2023. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 17.08.2023. Patent Number: AU2021306597. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
R&D Projects: GA MŠMT(CZ) EF16_019/0000729
Institutional support: RVO:61388963
Keywords : STING * cyclic dinucleotide * oncology
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/071575129/publication/AU2021306597B2?q=AU2021306597B2
Permanent Link: https://hdl.handle.net/11104/0349367 - 2.0578786 - ÚOCHB 2024 RIV eng P - Patent Document
Birkuš, Gabriel - Břehová, Petra - Dejmek, Milan - Nencka, Radim - Páv, Ondřej - Šála, Michal
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as STING modulator.
2023. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 26.09.2023. Patent Number: US11766447. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
R&D Projects: GA MŠMT(CZ) EF16_019/0000729
Institutional support: RVO:61388963
Keywords : STING * cyclic dinucleotide * oncology
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/069845481/publication/US11766447B2?q=US11766447B2
Permanent Link: https://hdl.handle.net/11104/0347697 - 3.0573168 - ÚOCHB 2024 RIV eng P - Patent Document
Birkuš, Gabriel - Dejmek, Milan - Nencka, Radim - Otava, Tomáš - Šála, Michal - Páv, Ondřej
3'3' cyclic dinucleotides with an alkenylene.
2023. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 24.05.2023. Patent Number: EP3936514. Territorial Protection: evropský patent podle Evropské patentové úmluvy ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
R&D Projects: GA MŠMT(CZ) EF16_019/0000729
Institutional support: RVO:61388963
Keywords : STING * cyclic dinucleotide * oncology
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/071575129/publication/EP3936514B1?q=EP3936514B1
Permanent Link: https://hdl.handle.net/11104/0343628 - 4.0552130 - ÚOCHB 2022 RIV kor P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
HIV를 치료하는데 사용되는 퀴나졸린 유도체.
[Quinazoline derivatives used to treat HIV.]
2021. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 11.08.2021. Patent Number: KR102288855
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/patent/search/family/055305044/publication/KR102288855B1?q=KR2288855
Permanent Link: http://hdl.handle.net/11104/0327279 - 5.0552007 - ÚOCHB 2022 RIV chi P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
用於治療 HIV 的喹唑啉衍生物.
[Quinazoline derivatives used to treat HIV.]
2020. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 10.01.2020. Patent Number: HK1244001
Institutional support: RVO:61388963
Keywords : reverse transcriptase * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
Permanent Link: http://hdl.handle.net/11104/0327194File Download Size Commentary Version Access sysno0552007-HK1244001.pdf 3 97 KB Publisher’s postprint open-access - 6.0552004 - ÚOCHB 2022 RIV ukr P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
ПОХІДНІ ХІНАЗОЛІНУ, ЩО ЗАСТОСОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ ВІЛ.
[Quinazoline derivatives used to treat HIV.]
2018. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 25.09.2018. Patent Number: UA117796
Institutional support: RVO:61388963
Keywords : reverse transcriptase * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
Permanent Link: http://hdl.handle.net/11104/0327193File Download Size Commentary Version Access sysno0552004-UA117796.pdf 3 4.2 MB Publisher’s postprint open-access - 7.0547788 - ÚOCHB 2022 RIV eng P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
Quinazoline derivatives used to treat HIV.
2021. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 25.08.2021. Patent Number: EP3521282
Institutional support: RVO:61388963
Keywords : reverse transcriptase * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210825&DB=&locale=en_EP&CC=EP&NR=3521282B1&KC=B1&ND=4
Permanent Link: http://hdl.handle.net/11104/0323964 - 8.0534505 - ÚOCHB 2021 RIV eng P - Patent Document
Baszczyňski, Ondřej - Dejmek, Milan - Hu, Y. E. - Jansa, Petr - Lansdon, E. - Mackman, R. - Šimon, Petr
Quinazoline compounds.
2019. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 19.02.2019. Patent Number: US10206926
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=10206926B2&KC=B2&FT=D&ND=4&date=20190219&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312841 - 9.0534384 - ÚOCHB 2021 RIV chi P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
喹唑啉化合物.
[Quinazoline compounds.]
2020. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.07.2020. Patent Number: TWI699355
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=TW&NR=I699355B&KC=B&FT=D&ND=4&date=20200721&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312833 - 10.0534281 - ÚOCHB 2021 RIV spa P - Patent Document
Mackman, R. - Jansa, Petr - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Lansdon, E. - Šimon, Petr
Derivados de quinazolina usados para tratar el virus de inmunodeficiencia humana (VIH).
[Quinazoline derivatives used to treat HIV.]
2019. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 27.08.2019. Patent Number: MX367574
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190827&DB=&locale=en_EP&CC=MX&NR=367574B&KC=B&ND=4
Permanent Link: http://hdl.handle.net/11104/0312554